2019
DOI: 10.1134/s1070363219030228
|View full text |Cite
|
Sign up to set email alerts
|

Design, Synthesis, and Anticancer Activity of Amide Derivatives of Structurally Modified Combretastatin-A4

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…In addition, from the chemical point of view, such a change at position C10 allows obtaining compounds more resistant to acid hydrolysis [29,30,33]. We have decided to check various amide and sulfonamide moieties because they have long been valued for their rich biological and chemical profiles and have emerged as a promising class of compounds in drug discovery [37][38][39][40][41].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, from the chemical point of view, such a change at position C10 allows obtaining compounds more resistant to acid hydrolysis [29,30,33]. We have decided to check various amide and sulfonamide moieties because they have long been valued for their rich biological and chemical profiles and have emerged as a promising class of compounds in drug discovery [37][38][39][40][41].…”
Section: Introductionmentioning
confidence: 99%
“…In this investigation, we demonstrated that both MDA-MB-231 (a highly metastatic and poorly differentiated cell line) and MDA-MB-468 (a metastatic and less differentiated cell line) that represent a TNBC subtype, were sensitized towards cisplatin by supplementation with an ethanolic leaf extract of C. nutans known to be enriched with compounds possessing anticancer properties. 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 46 This sensitization can be proven via the achievement of a lower cisplatin IC 50 concentration by 50% upon the treatment of addition of MDA-MB-231 cells with C. nutans ( Figure 1 H). In addition, the metastatic potential of MDA-MB-231 cells was significantly inhibited by almost 50% when treated with 3.05 μg/mL cisplatin + 10 μg/mL C. nutans when compared to 3.05 μg/mL cisplatin treatment.…”
Section: Discussionmentioning
confidence: 95%
“…A total of 18 major bioactive compounds with potential anticancer properties were identified by ethanol extraction. 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 Of these, fatty acid derivatives (28.34%), carboxylic acid ester derivatives (26.68%), and glycoside derivatives (22.47%), were the major constituents of C. nutans leaf extract ( Table 4 ).…”
Section: Resultsmentioning
confidence: 99%